Johnson & Johnson was founded in 1886 and is headquartered in New Brunswick, US
Report incorrect company information
Key People/Management at Johnson & Johnson
Ian Davis
Vice President Global Professional Affairs
Sandra Peterson
Group Worldwide Chair
Michael Ullmann
Executive Vice President, General Counsel
Paul Stoffels
Executive Vice President, Chief Scientific Officer
Alex Gorsky
Chairman, Board of Directors and Chief Executive Officer
Jorge Mesquita
Executive Vice President, Worldwide Chairman, Consumer
Report incorrect company information
Johnson & Johnson Office Locations
Johnson & Johnson has offices in Neenah, Solothurn, Zug, Dhaka and in 24 other locations
New Brunswick, US (HQ)
One Johnson & Johnson Plaza
Greenville, US
204 Greenville Blvd SW
Solothurn, CH
21 Luzernstrasse
Zug, CH
Gubelstrasse 34, 6300
Report incorrect company information
Johnson & Johnson Financials and Metrics
Johnson & Johnson Financials
Johnson & Johnson's revenue was reported to be $71.89 b in FY, 2017 which is a 2.6% increase from the previous period.
| USD | |
|---|---|
Revenue (Q3, 2018) | 19.7 b |
Gross profit (Q3, 2018) | 12.7 b |
Gross profit margin (Q3, 2018), % | 64.9% |
Net income (Q3, 2018) | 3.8 b |
Market capitalization (23-Apr-2018) | 348.2 b |
Cash (1-Oct-2017) | 15.7 b |
EV | 367.6 b |
Johnson & Johnson's current market capitalization is $348.2 b.
Annual
Quarterly
| USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|
Revenue | 17.4 b | 17.8 b | 17.1 b | 17.5 b | 18.5 b | 17.8 b | 17.8 b | 18.8 b | 19.7 b |
Cost of goods sold | 5.3 b | 5.4 b | 5.2 b | 5.3 b | 5.3 b | 5.5 b | 5.4 b | 5.8 b | 6.9 b |
Gross profit | 12.1 b | 12.4 b | 11.9 b | 12.2 b | 13.1 b | 12.3 b | 12.4 b | 13 b | 12.7 b |
Gross profit Margin, % | 70% | 70% | 69% | 70% | 71% | 69% | 70% | 69% | 65% |
Annual
| USD | FY, 2013 | FY, 2014 | FY, 2016 | FY, 2017 |
|---|---|---|---|---|
Cash | 20.9 b | 14.5 b | 13.7 b | 19 b |
Accounts Receivable | 11.7 b | 11 b | 10.7 b | 11.7 b |
Prepaid Expenses | 4 b | 3.5 b | 3 b | 3.3 b |
Inventories | 7.9 b | 8.2 b | 8.1 b | 8.1 b |
Quarterly
| USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|
Cash | 12 b | 10.6 b | 13.6 b | 13.9 b | 18.6 b | 18.2 b | 20.9 b | 12.6 b | 15.7 b |
Accounts Receivable | 11.5 b | 12 b | 11.4 b | 11.4 b | 12.1 b | 11.8 b | 12.3 b | 13.3 b | 13.2 b |
Prepaid Expenses | 3.7 b | 3.1 b | 3 b | 3.3 b | 3.1 b | 2.6 b | 2.8 b | 3 b | 2.9 b |
Inventories | 8.1 b | 8.3 b | 8.2 b | 8.2 b | 8.5 b | 8.5 b | 8.9 b | 9.7 b | 9.5 b |
Annual
| USD | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|
Net Income | 13.8 b | 16.3 b | 15.4 b | 16.5 b |
Depreciation and Amortization | 4.1 b | 3.9 b | 3.7 b | 3.8 b |
Inventories | (622 m) | (1.1 b) | (449 m) | (249 m) |
Accounts Payable | 1.8 b | 955 m | (3 m) | 656 m |
Quarterly
| USD | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 |
|---|---|---|---|---|---|---|---|---|---|
Net Income | 4.3 b | 8.8 b | 12.2 b | 4.3 b | 8.5 b | 12.7 b | 4.4 b | 8.2 b | 12 b |
Depreciation and Amortization | 895 m | 1.8 b | 2.7 b | 891 m | 1.8 b | 2.7 b | 912 m | 2.1 b | 3.8 b |
Inventories | (276 m) | (537 m) | (719 m) | (190 m) | (443 m) | (408 m) | (368 m) | (421 m) | (193 m) |
Accounts Payable | (2.5 b) | (2.2 b) | 1.6 b | (2.3 b) | (1 b) | (1.2 b) | (2 b) | (1.2 b) | 339 m |
| USD | Y, 2017 |
|---|---|
EV/CFO | 24.6 x |
Revenue/Employee | 155.5 k |
Debt/Equity | 0.5 x |
Debt/Assets | 0.2 x |
Financial Leverage | 2.1 x |
Johnson & Johnson Acquisitions / Subsidiaries
| Acquired Company | Date | Deal Size |
|---|---|---|
| Lifescan (France) | ||
| Johnson & Johnson Taiwan Ltd. | ||
| Johnson & Johnson, S.A. de C.V. | ||
| Mentor Medical Systems B.V. | ||
| Omrix Biopharmaceuticals Ltd. | ||
| Penta Pty. Limited | ||
| PMC Holdings G.K. | ||
| Turnbuckle Investment Company | ||
| Acclarent | ||
| Advanced Sterilization Products Services Inc. |
Report incorrect company information
